Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation (Q46069078)

19 December 2017

title

Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation (English)

1 reference

19 December 2017

0 references

1 reference

1 reference

Yu Chen

1

1 reference

19 December 2017

Jaclyn Biada

series ordinal

2

1 reference

19 December 2017

Sumita Sood

series ordinal

3

1 reference

19 December 2017

Ralph Rabkin

series ordinal

4

1 reference

19 December 2017

language of work or name

English

0 references

publication date

7 April 2010

1 reference

19 December 2017

published in

Kidney International

1 reference

19 December 2017

volume

78

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

89-95

1 reference

19 December 2017

Why is protein-energy wasting associated with mortality in chronic kidney disease?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

The growth hormone-insulin-like growth factor-I axis in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Cardiac resistance to growth hormone in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Growth hormone treatment in hemodialysis patients--a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

New insights into growth hormone action.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

In vivo regulation of growth hormone-stimulated gene transcription by STAT5b

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Aspects of immune dysfunction in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Epidemiology of acute infections among patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Molecular aspects of endotoxins relevant to their biological functions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Clinical effects of polymyxin B-immobilized fiber column in septic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Ultrapure dialysate: facts and myths

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Negative regulation of growth hormone receptor signaling.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Suppressors of cytokine signaling in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.85

7 January 2021

Identifiers

DOI

10.1038/KI.2010.85

1 reference

19 December 2017

Dimensions Publication ID

1005708525

0 references

1 reference

19 December 2017